Who Owns Nektar Therapeutics Stock?
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 107.08%
- Institutions (% of float)
- 107.49%
- Held by insiders
- 0.38%
- Institutional holders
- 313
- Institutions 99.6%
- Insiders 0.4%
- Public and other 0.0%
Who owns Nektar Therapeutics stock?
Institutional investors own about 107.1% of Nektar Therapeutics's shares, spread across 313 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.38% of NKTR.
The largest institutional holders are FMR, LLC (14.84%), Two Seas Capital Lp (9.80%) and Blackrock Inc. (8.62%). Together, the top 10 institutions control 59.1% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their NKTR positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NKTR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 5.07M | 14.84% | +17.8% |
| Two Seas Capital Lp | 3.35M | 9.80% | +8.2% |
| Blackrock Inc. | 2.94M | 8.62% | +324.7% |
| BVF Inc. | 2.39M | 7.00% | -6.6% |
| Vanguard Capital Management LLC | 1.50M | 4.38% | +25.0% |
| Two Sigma Investments, LP | 1.20M | 3.52% | +29.1% |
| Vestal Point Capital, LP | 1.00M | 2.93% | +250.9% |
| Morgan Stanley | 936.56K | 2.74% | +42.0% |
| State Street Corporation | 909.68K | 2.66% | +271.7% |
| Geode Capital Management, LLC | 881.31K | 2.58% | +154.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NKTR
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.85M | 5.42% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.08M | 3.15% |
| iShares Trust-iShares Russell 2000 ETF | 882.67K | 2.59% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 500.35K | 1.47% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 424.55K | 1.24% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 387.57K | 1.14% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 376.89K | 1.10% |
| iShares Trust-iShares Russell 2000 Growth ETF | 289.53K | 0.85% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 172.42K | 0.50% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 166.58K | 0.49% |
Frequently asked questions
Who is the largest shareholder of Nektar Therapeutics?
FMR, LLC is the largest institutional shareholder of NKTR, owning 14.84% of shares outstanding (5.07M shares) as of its latest 13F filing.
What percentage of Nektar Therapeutics is owned by institutions?
Institutions own about 107.1% of NKTR shares and 107.5% of the public float.
How much of Nektar Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.38% of NKTR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.